Want to see HK:6669 full AI Analyst Report?
Acotec Scientific Holdings Limited (6669) Ratios
Acotec Scientific Holdings Limited Ratios
HK:6669's free cash flow for Q2 2026 was $-10.19M. For the 2026 fiscal year, HK:6669's free cash flow was decreased by $-11.09M and operating cash flow was $899.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.73 | 8.98 | 10.42 | 12.73 | 14.11 |
| Quick Ratio | 5.19 | 7.82 | 9.12 | 11.55 | 13.64 |
| Cash Ratio | 1.71 | 5.57 | 5.49 | 10.00 | 12.91 |
| Solvency Ratio | 0.44 | 0.33 | 0.19 | 0.67 | -0.67 |
| Operating Cash Flow Ratio | 0.72 | 0.76 | -0.11 | -0.70 | -0.12 |
| Short-Term Operating Cash Flow Coverage | 2.45 | 10.28 | -1.29 | 0.00 | -1.75 |
| Net Current Asset Value | $ 945.28M | $ 897.81M | $ 896.60M | $ 1.12B | $ 1.14B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.12 | 0.15 | 0.03 | 0.02 |
| Debt-to-Equity Ratio | 0.17 | 0.15 | 0.18 | 0.04 | 0.02 |
| Debt-to-Capital Ratio | 0.14 | 0.13 | 0.15 | 0.04 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.27 | 1.23 | 1.24 | 1.11 | 1.08 |
| Debt Service Coverage Ratio | 2.02 | 5.22 | 3.56 | 64.31 | -6.40 |
| Interest Coverage Ratio | 14.19 | 5.56 | 2.54 | 50.94 | 16.58 |
| Debt to Market Cap | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.84 | 0.71 | 0.81 | 0.16 | 0.11 |
| Net Debt to EBITDA | -0.98 | -4.88 | -5.72 | -10.30 | 21.81 |
| Profitability Margins | |||||
| Gross Profit Margin | 73.89% | 75.42% | 79.65% | 85.04% | 87.53% |
| EBIT Margin | 16.41% | 11.70% | 5.13% | 18.14% | -20.87% |
| EBITDA Margin | 24.74% | 21.06% | 14.89% | 23.05% | -16.79% |
| Operating Profit Margin | 20.66% | 11.99% | 5.28% | 18.22% | 20.87% |
| Pretax Profit Margin | 18.95% | 9.85% | 3.05% | 17.78% | -22.13% |
| Net Profit Margin | 18.49% | 9.79% | 3.06% | 17.73% | -26.03% |
| Continuous Operations Profit Margin | 18.49% | 9.79% | 3.06% | 17.73% | -26.03% |
| Net Income Per EBT | 97.55% | 99.39% | 100.24% | 99.75% | 117.60% |
| EBT Per EBIT | 91.76% | 82.18% | 57.79% | 97.56% | -106.03% |
| Return on Assets (ROA) | 6.38% | 3.14% | 0.90% | 4.97% | -6.05% |
| Return on Equity (ROE) | 8.07% | 3.87% | 1.12% | 5.50% | -6.55% |
| Return on Capital Employed (ROCE) | 8.14% | 4.19% | 1.67% | 5.49% | 5.20% |
| Return on Invested Capital (ROIC) | 7.51% | 4.07% | 1.63% | 5.43% | 5.15% |
| Return on Tangible Assets | 6.77% | 3.16% | 0.90% | 4.99% | -6.07% |
| Earnings Yield | 3.26% | 3.10% | 0.47% | 1.54% | -3.42% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.69 | 3.31 | 3.13 | 3.00 | 6.87 |
| Payables Turnover | 3.45 | 3.36 | 5.00 | 2.14 | 5.31 |
| Inventory Turnover | 1.33 | 0.84 | 0.64 | 0.51 | 0.91 |
| Fixed Asset Turnover | 2.02 | 1.63 | 1.34 | 3.31 | 5.34 |
| Asset Turnover | 0.34 | 0.32 | 0.29 | 0.28 | 0.23 |
| Working Capital Turnover Ratio | 0.59 | 0.49 | 0.42 | 0.34 | 0.63 |
| Cash Conversion Cycle | 305.42 | 435.45 | 615.01 | 669.36 | 384.77 |
| Days of Sales Outstanding | 135.81 | 110.26 | 116.63 | 121.72 | 53.12 |
| Days of Inventory Outstanding | 275.40 | 433.75 | 571.38 | 717.98 | 400.46 |
| Days of Payables Outstanding | 105.79 | 108.56 | 73.01 | 170.35 | 68.80 |
| Operating Cycle | 411.20 | 544.01 | 688.01 | 839.70 | 453.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.55 | 0.34 | -0.04 | -0.23 | -0.04 |
| Free Cash Flow Per Share | 0.48 | 0.02 | -0.31 | -0.39 | -0.13 |
| Dividend Paid and CapEx Coverage Ratio | 7.65 | 1.05 | -0.16 | -1.47 | -0.03 |
| Capital Expenditure Coverage Ratio | 7.65 | 1.05 | -0.16 | -1.47 | -0.49 |
| Operating Cash Flow Coverage Ratio | 0.68 | 0.51 | -0.06 | -1.44 | -0.43 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.19 | -0.03 | -0.17 | -0.03 |
| Free Cash Flow Yield | 3.97% | 0.31% | -3.01% | -2.54% | -1.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 31.09 | 32.29 | 212.42 | 64.80 | -29.27 |
| Price-to-Sales (P/S) Ratio | 5.68 | 3.16 | 6.49 | 11.49 | 7.62 |
| Price-to-Book (P/B) Ratio | 2.48 | 1.25 | 2.37 | 3.56 | 1.92 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 25.17 | 317.86 | -33.25 | -39.37 | -72.97 |
| Price-to-Operating Cash Flow Ratio | 21.88 | 16.42 | -238.86 | -66.11 | -220.88 |
| Price-to-Earnings Growth (PEG) Ratio | 0.24 | 0.13 | -2.69 | -0.38 | -0.23 |
| Enterprise Value Multiple | 21.99 | 10.13 | 37.90 | 39.56 | -23.56 |
| Enterprise Value | 3.51B | 1.14B | 2.67B | 3.61B | 1.20B |
| EV to EBITDA | 21.99 | 10.13 | 37.90 | 39.56 | -23.56 |
| EV to Sales | 5.44 | 2.13 | 5.64 | 9.12 | 3.96 |
| EV to Free Cash Flow | 24.10 | 214.59 | -28.89 | -31.24 | -37.89 |
| EV to Operating Cash Flow | 20.95 | 11.09 | -207.53 | -52.45 | -114.69 |
| Tangible Book Value Per Share | 4.54 | 4.46 | 4.29 | 4.24 | 4.87 |
| Shareholders’ Equity Per Share | 4.89 | 4.48 | 4.31 | 4.26 | 4.89 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.01 | -0.00 | 0.00 | -0.18 |
| Revenue Per Share | 2.13 | 1.77 | 1.57 | 1.32 | 1.23 |
| Net Income Per Share | 0.39 | 0.17 | 0.05 | 0.23 | -0.32 |
| Tax Burden | 0.98 | 0.99 | 1.00 | 1.00 | 1.18 |
| Interest Burden | 1.15 | 0.84 | 0.60 | 0.98 | 1.06 |
| Research & Development to Revenue | 0.33 | 0.41 | 0.40 | 0.46 | 0.47 |
| SG&A to Revenue | 0.28 | 0.30 | 0.18 | 0.22 | 0.33 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.04 | 0.11 |
| Income Quality | 1.44 | 1.95 | -0.89 | -0.98 | 0.16 |
Currency in CNY
